Change Control. A Key Element of a Quality System

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "Change Control. A Key Element of a Quality System"

Transcription

1 IVT 9 th Annual Conference Change Control Change Control A Key Element of a Quality System Jerry Lanese Ph.D. CMC The Lanese Group, Inc The Lanese Group 1

2 Will discuss A Quality System What is it Purpose Quality System compared to other management systems Continuous improvement Integrated components of a Quality System 2011 The Lanese Group 2

3 What is a Quality System 2011 The Lanese Group 3

4 2011 The Lanese Group 4

5 2011 The Lanese Group 5

6 2011 The Lanese Group 6

7 2011 The Lanese Group 7

8 Management Review Change Control records Investigations Documents Production Controls Validation 2011 The Lanese Group 8

9 2011 The Lanese Group 9

10 ` 2011 The Lanese Group 10

11 Organizational Profile: Environment, Relationships, and Challenges Strategic Planning Human Resource Focus Leadership Business Results Customer and Market Focus Process Management 2011 The Lanese Group Measurement, Analysis and Knowledge Management 11 Baldrige

12 Baldrige Organizational Profile 1. Leadership 2. Strategic Planning 3. Customer and Market Focus 4. Measurement, Analysis, and Knowledge Management 5. Human Resource Focus 6. Process Management 7. Business Results

13 Continual Improvement of the quality management system Management Responsibility Customers Customers Resource Management Measurement, Analysis and Improvement Requirements Input Product Realization QMS Output Product Satisfaction ISO

14 Management Design Controls Production & Process Controls Material Controls Corrective & Preventive Actions Records, Documents, & Change Controls Equipment & Facility Controls Controls 2011 The Lanese Group 14 FDA QSIT Presentation

15 Medical Device Reporting Reports of Corrections and Removals Medical Device Tracking Facility & Equipment Controls Corrective & Preventive Actions Design Controls MANAGEMENT 2011 The Lanese Group Material Controls Records/ Documents/ Change Controls 15 Production & Process Controls Sterilization Process Controls FDA QSIT Presentation

16 Production System Quality Packaging & Labeling System Facilities & Equipment System System Materials System Laboratory Controls System

17 Purpose of a XXX Quality System To enhance the quality and availability of products around the world in the interest of public health. Facilitate innovation and continual improvement and strengthen the link between development and manufacturing activities The Lanese Group 17

18 What is in the Quality System 2011 The Lanese Group 18

19 Process Performance and Product Quality Monitoring Corrective Action Preventive Action Change Management Management Review of Process Performance and Product Quality Elements that promote the life-cycle approach ICH Q7A Regional EU GMP GMPs 21CFR 210, 21CFR211 Regional GMPs 2011 The Lanese Group 19

20 Process Performance and Product Quality Monitoring Corrective Action Preventive Action Change Management Management Review of Process Performance and Product Quality ICH Q7A EU GMP 21CFR 210, 21CFR211 Regional GMPs 2011 The Lanese Group 20

21 Process Performance and Product Quality Monitoring Corrective Action Preventive Action Change Management Management Review of Process Performance and Product Quality ICH Q7A EU GMP 21CFR 210, 21CFR211 Regional GMPs 2011 The Lanese Group Product Realization ICH Q10 State of Control Objectives Continual Improvement 21

22 ICH Q10 Pharmaceutical Quality System Pharmaceutical Development Technology Transfer Commercial Manufacturing Product Discontinuance Investigational Products GMP Management Responsibilities PQS Elements Process Performance and Product Quality Monitoring System Corrective Action/Preventive Action (CAPA) System Change Management System Management Review Enablers 2011 The Lanese Group Knowledge Management Quality Risk Management 22 ICH Q10 4 June 2008

23 Product Lifecycle Corporate Support and Management Operations Develop Commercialize Discovery Transfer Discontinuation 2011 The Lanese Group 23

24 Product Lifecycle Corporate Support and Management Operations Develop GMPs Commercialize Discovery Transfer Discontinuation 2011 The Lanese Group 24

25 Product Lifecycle Corporate Support and Management Operations Develop Six Commercialize Systems Discovery Transfer Discontinuation 2011 The Lanese Group 25

26 Product Lifecycle Corporate Support and Management Operations Develop Baldrige Commercialize Discovery Transfer Discontinuation 2011 The Lanese Group 26

27 Product Lifecycle Corporate Support and Management Operations Develop ICH Q10 Commercialize Discovery Transfer Discontinuation 2011 The Lanese Group 27

28 Development Change management 2011 The Lanese Group 28

29 Change Change Management 2011 The Lanese Group 29

30 Requirement for change control These written procedures, including any changes, shall be drafted, reviewed, and approved by the appropriate organizational units and reviewed and approved by the quality control unit. 21CFR (a) 2011 The Lanese Group 30

31 Requirement for change control The establishment of any specifications, standards, sampling plans, test procedures, or other laboratory control mechanisms required by this subpart, including any change in such specifications, standards, sampling plans, test procedures, or other laboratory control mechanisms, shall be drafted by the appropriate organizational unit and reviewed and approved by the quality control unit The Lanese Group 31 21CFR (a)

32 Requirement for change control Document changes. Changes to documents shall be reviewed and approved by an individual(s) in the same function or organization that performed the original review and approval, unless specifically designated otherwise. 21CFR820.40(b) 2011 The Lanese Group 32

33 Requirement for change control Approved changes shall be communicated to the appropriate personnel in a timely manner. Each manufacturer shall maintain records of changes to documents. 21CFR820.40(b) 2011 The Lanese Group 33

34 Requirement for change control Change records shall include a description of the change, identification of the affected documents, the signature of the approving individual(s), the approval date, and when the change becomes effective. 21CFR820.40(b) 2011 The Lanese Group 34

35 Requirement for change control Production and process changes. Each manufacturer shall establish and maintain procedures for changes to a specification, method, process, or procedure. Such changes shall be verified or where appropriate validated according to , before implementation and these activities shall be documented. Changes shall be approved in accordance with The Lanese Group 35 21CFR820.70(b)

36 Change Control A formal change control system should be established to evaluate all changes that could affect the production and control of the intermediate or API. ICH Q7; The Lanese Group 36

37 Change Control Written procedures should provide for the identification, documentation, appropriate review, and approval of changes in raw materials, specifications, analytical methods, facilities, support systems, equipment (including computer hardware), processing steps, labeling and packaging materials, and computer software. ICH Q7; The Lanese Group 37

38 Change Control Any proposals for GMP relevant changes should be drafted, reviewed, and approved by the appropriate organizational units and reviewed and approved by the quality unit(s). ICH Q7; The Lanese Group 38

39 Change Control The potential impact of the proposed change on the quality of the intermediate or API should be evaluated. A classification procedure may help in determining the level of testing, validation, and documentation needed to justify changes to a validated process. ICH Q7; The Lanese Group 39

40 Change Control Changes can be classified (e.g., as minor or major) depending on the nature and extent of the changes, and the effects these changes may impart on the process. Scientific judgment should determine what additional testing and validation studies are appropriate to justify a change in a validated process The Lanese Group 40 ICH Q7; 13

41 Change Control When implementing approved changes, measures should be taken to ensure that all documents affected by the changes are revised. After the change has been implemented, there should be an evaluation of the first batches produced or tested under the change The Lanese Group 41 ICH Q7; 13

42 Change Control (definition) A formal system by which qualified representatives of appropriate disciplines review proposed or actual changes that might affect the validated status of facilities, systems, equipment or processes. The intent is to determine the need for action that would ensure and document that the system is maintained in a validated state The Lanese Group 42 EU GMP; Annex 15

43 Change Control (definition) A formal system in which proposed changes are evaluated and monitored to assure that they result in products of equal or improved quality, process of equal or improved efficiency and compliance while maintaining appropriate regulatory submissions. Lanese 2011 The Lanese Group 43

44 Responsibilities of the Change Control Program Review all changes proposed for the GMP facilities, equipment, materials, processes to determine if there is a potential impact on product quality 2011 The Lanese Group 44

45 Responsibilities of the Change Control Program If there is potential impact: Inform all appropriate units of the potential impact. Coordinate appropriate regulatory submissions. Assure that the proposed change is completed in a timely manner and required changes to documentation and other supporting systems are made. Verify that the change achieves its intended purpose The Lanese Group 45

46 ICH Q10 Pharmaceutical Quality System Pharmaceutical Development Technology Transfer Commercial Manufacturing Product Discontinuance Investigational Products GMP Management Responsibilities PQS Elements Process Performance and Product Quality Monitoring System Corrective Action/Preventive Action (CAPA) System Change Management System Management Review Enablers 2011 The Lanese Group Knowledge Management Quality Risk Management 46 ICH Q10 4 June 2008

47 Main objectives of a Quality System Achieve product realization Establish and maintain a state of control Facilitate continual improvement ICH Q The Lanese Group 47

48 P plan A act D do C check

49 Requirements Inputs Overview of a Modern Pharmaceutical Quality System Continual Improvement Act Management Resources Manufacturing Evaluation Plan Do Check Quality System Infrastructure Quality by Design Risk Management Chris Joneckis, PhD, FDA

50 Continual Improvement of the quality management system Management Responsibility Customers Customers Resource Management Measurement, Analysis and Improvement Requirements Input Product Realization QMS Output Product Satisfaction ISO

51 PDCA Plan: Put in place all of supporting system changes to support the overall change Do: Implement the changed process. Check: Verify - Monitor and measure the processes and product against established performance measures Act: Recommend the next change to continually improve process performance

52 ICH Q10 Pharmaceutical Quality System Pharmaceutical Development Technology Transfer Commercial Manufacturing Product Discontinuance Investigational Products GMP Management Responsibilities PQS Elements Process Performance and Product Quality Monitoring System Corrective Action/Preventive Action (CAPA) System Change Management System Management Review Enablers 2011 The Lanese Group Knowledge Management Quality Risk Management 52 ICH Q10 4 June 2008

53 Corrective action/preventive action Development Not applicable, CAPA incorporated into interactive design process Technology transfer Provides feedback on the effectivity of the development process Manufacturing A formal quality system, adds to knowledge database Product Discontinuance Investigations evaluate impact on remaining product and other products 2011 The Lanese Group 53

54 Change Management Development Documents all changes - increases formality of the process as product matures Technology transfer Key knowledge transfer tool Manufacturing Formal system must be in place Product Discontinuance Records maintained and destroyed after retention period 2011 The Lanese Group 54

55 Product Reviews Validate Verify Inspectional Observations Development Change Audit Observations CAPA Deviations Product Monitoring Investigations 2011 The Lanese Group 55

56 Change Management System Change Control System Senior Management 2011 The Lanese Group 56

57 Recommend Change 2011 The Lanese Group 57

58 Product Reviews Validate Verify Inspectional Observations Development Change Audit Observations CAPA Deviations Product Monitoring Investigations 2011 The Lanese Group 58

59 Recommend Change Log into project management system Prepare forms required by CM program Estimate costs 2011 The Lanese Group 59

60 Require Mgmt Approval No No Yes Require Change Control Yes Management approves funding 2011 The Lanese Group 60

61 Manage Change Project Implement Change Initiate CC Forms Define CC requirements, communicate Monitor Change Project 2011 The Lanese Group 61

62 CC Project Yes Perform Verification Tests Evaluate Verification Date 2011 The Lanese Group 62

63 Close out project Meet Criteria Yes Close out Change Control Documents 2011 The Lanese Group 63

64 ICH Q10 Pharmaceutical Quality System Pharmaceutical Development Technology Transfer Commercial Manufacturing Product Discontinuance Investigational Products GMP Management Responsibilities PQS Elements Process Performance and Product Quality Monitoring System Corrective Action/Preventive Action (CAPA) System Change Management System Management Review Enablers 2011 The Lanese Group Knowledge Management Quality Risk Management 64 ICH Q10 4 June 2008

65 2011 The Lanese Group 65

66 Develop a Quality System that fits the business and compliance needs 2011 The Lanese Group 66

67 Contact Information Jerry Lanese Ph.D. The Lanese Group, Inc Catalina Leawood, KS The Lanese Group 67

68 IVT 9 th Annual Conference Change Control Change Control A Key Element of a Quality System Jerry Lanese Ph.D. CMC The Lanese Group, Inc The Lanese Group 68

Guidance for Industry. Q10 Pharmaceutical Quality System

Guidance for Industry. Q10 Pharmaceutical Quality System Guidance for Industry Q10 Pharmaceutical Quality System U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation

More information

PHARMACEUTICAL QUALITY SYSTEM Q10

PHARMACEUTICAL QUALITY SYSTEM Q10 INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE PHARMACEUTICAL QUALITY SYSTEM Q10 Current Step

More information

Best Practice In A Change Management System

Best Practice In A Change Management System Quality & Compliance Associates, LLC Best Practice In A Change Management System President Quality & Compliance Associates, LLC Change Control and Its Role in a Continuous Improvement Environment 3 Benefits

More information

Pharmaceutical Quality Management System: Current Concept

Pharmaceutical Quality Management System: Current Concept Pharmaceutical Quality Management System: Current Concept Neetu Dubey 1, *, Himanshu Gupta 3, R.K. Sharma 2, Nitin Dubey 1, Nidhi Dubey 4 1. IPS Academy, Indore, Madhya Pradesh, India. 2. Prestige Institute

More information

MHRA GMP Data Integrity Definitions and Guidance for Industry January 2015

MHRA GMP Data Integrity Definitions and Guidance for Industry January 2015 MHRA GMP Data Integrity Definitions and Guidance for Industry Introduction: Data integrity is fundamental in a pharmaceutical quality system which ensures that medicines are of the required quality. This

More information

ASSESSMENT OF QUALITY RISK MANAGEMENT IMPLEMENTATION

ASSESSMENT OF QUALITY RISK MANAGEMENT IMPLEMENTATION PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 038-1 26 March 2012 AIDE-MEMOIRE ASSESSMENT OF QUALITY RISK MANAGEMENT IMPLEMENTATION PIC/S March 2012 Reproduction

More information

How to implement a Quality Management System

How to implement a Quality Management System How to implement a Quality Management System This whitepaper will help you to implement a Quality Management System (QMS), based on Good Manufacturing Practice (GMP), ISO 9001 or ISO 13485 within your

More information

Introduction to Q10 Pharmaceutical Quality System

Introduction to Q10 Pharmaceutical Quality System ICH-GCG Asean Training Workshop on ICH Guidelines Q8,Q9 and Q10 (New Paradigm) Introduction to Q10 Pharmaceutical Quality System Georges FRANCE, Q- IWG Kuala Lumpur, Malaysia 26-28 July 2010 International

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Q8, Q9, and Q10 Questions and Answers(R4) U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics

More information

MHRA GMP Data Integrity Definitions and Guidance for Industry March 2015

MHRA GMP Data Integrity Definitions and Guidance for Industry March 2015 MHRA GMP Data Integrity Definitions and Guidance for Industry Introduction: Data integrity is fundamental in a pharmaceutical quality system which ensures that medicines are of the required quality. This

More information

QSIT Management Controls. QSIT Workshops

QSIT Management Controls. QSIT Workshops QSIT Management Controls QSIT Workshops Management Controls Importance Assessment Demonstration of Compliance Quality System Design Controls Material Controls Corrective & Preventive Actions Management

More information

This interpretation of the revised Annex

This interpretation of the revised Annex Reprinted from PHARMACEUTICAL ENGINEERING The Official Magazine of ISPE July/August 2011, Vol. 31 No. 4 www.ispe.org Copyright ISPE 2011 The ISPE GAMP Community of Practice (COP) provides its interpretation

More information

Guidance for Industry Quality Systems Approach to Pharmaceutical CGMP Regulations

Guidance for Industry Quality Systems Approach to Pharmaceutical CGMP Regulations Guidance for Industry Quality Systems Approach to Pharmaceutical CGMP Regulations U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER)

More information

GOOD DOCUMENTATION AND QUALITY MANAGEMENT PRINCIPLES. Vimal Sachdeva Technical Officer (Inspector), WHO Prequalification of Medicines Programme

GOOD DOCUMENTATION AND QUALITY MANAGEMENT PRINCIPLES. Vimal Sachdeva Technical Officer (Inspector), WHO Prequalification of Medicines Programme GOOD DOCUMENTATION AND QUALITY MANAGEMENT PRINCIPLES Vimal Sachdeva Technical Officer (Inspector), WHO Prequalification of Medicines Programme Contents 1. Why good documentation is essential? 2. What constitutes

More information

Quality Management System (QMS) for Active Pharmaceutical Ingredients (API) Manufacturers

Quality Management System (QMS) for Active Pharmaceutical Ingredients (API) Manufacturers Quality Management System (QMS) for Active Pharmaceutical Ingredients (API) Manufacturers integrating GMP (ICH Q7a) into ISO (9001: 2000) September 2005 Quality Management System - integrating GMP (ICH

More information

Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations

Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations Kevin O Donnell PhD Market Compliance Manager, IMB PDA / FDA Conference Pharmaceutical

More information

1 The quality management system (QMS) is the corner stone of compliance to GMP. The QMS is made up of several documents, that when followed ensures the GMP compliance of the process, facility and company.

More information

2014 Annual FDA Medical Device Quality System Data. FDA Form 483 Observations and Warning Letter Citations

2014 Annual FDA Medical Device Quality System Data. FDA Form 483 Observations and Warning Letter Citations 2014 Annual FDA Medical Device Quality System Data FDA Form 483 Observations and Warning Letter Citations Why is FDA making these data available? In support of the FDA s Transparency and Case for Quality

More information

Author General Management Quality Assurance

Author General Management Quality Assurance Lab Ofichem B.V. Pag.: 1 / 14 Date: 20-01- Version: 02 Status: geldig Contents 1. General... 2 2. Shared Third Party audit program... 3 3. Reassurance absence of Conflict of Interest... 5 4. Contract structure...

More information

COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS

COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS Primer CONTENTS INTRODUCTION...3 QUALITY AND COMPLIANCE IN QUALITY CONTROL LABORATORIES...5 Compliance

More information

Recent Updates on European Requirements and what QPs are expected to do

Recent Updates on European Requirements and what QPs are expected to do Recent Updates on European Requirements and what QPs are expected to do QP Forum 28/29 November 2013, Lisbon Dr. Bernd Renger Modified: Georg Goestl 1 Written Conformation for API-Import Actual Status

More information

INTRODUCTION. This book offers a systematic, ten-step approach, from the decision to validate to

INTRODUCTION. This book offers a systematic, ten-step approach, from the decision to validate to INTRODUCTION This book offers a systematic, ten-step approach, from the decision to validate to the assessment of the validation outcome, for validating configurable off-the-shelf (COTS) computer software

More information

Intland s Medical Template

Intland s Medical Template Intland s Medical Template Traceability Browser Risk Management & FMEA Medical Wiki Supports compliance with IEC 62304, FDA Title 21 CFR Part 11, ISO 14971, IEC 60601 and more INTLAND codebeamer ALM is

More information

Quality Agreement. by and between. Supplier Name. Address: and. Client Name: Address:

Quality Agreement. by and between. Supplier Name. Address: and. Client Name: Address: NOTE TO USERS This Quality Agreement template was developed by the Bulk Pharmaceutical Task Force (BPTF), an affiliate organization of the Society of Chemical Manufacturers and Affiliates (SOCMA), as a

More information

Standard of measurement by which efficiency, performance, progress, or quality of a plan, process, or product can be assessed 1.

Standard of measurement by which efficiency, performance, progress, or quality of a plan, process, or product can be assessed 1. Meaningful Metrics What is a Metric? Standard of measurement by which efficiency, performance, progress, or quality of a plan, process, or product can be assessed 1. A quality metric is a measurement of

More information

Working Party on Control of Medicines and Inspections. Final Version of Annex 16 to the EU Guide to Good Manufacturing Practice

Working Party on Control of Medicines and Inspections. Final Version of Annex 16 to the EU Guide to Good Manufacturing Practice Version 8 (final) EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, regulatory environment, industries under vertical legislation Pharmaceuticals and cosmetics Brussels, July 2001 S\common\legal-legislation\75-319nd81-851\91-356\eudralexvol4\Annex

More information

The purpose of this Supplier Quality Standard is to communicate the expectations and requirements of Baxter Healthcare Corporation to its suppliers.

The purpose of this Supplier Quality Standard is to communicate the expectations and requirements of Baxter Healthcare Corporation to its suppliers. Supplier Quality Standard 1.0 Purpose The purpose of this Supplier Quality Standard is to communicate the expectations and requirements of Baxter Healthcare Corporation to its suppliers. These expectations

More information

Multivariate Tools for Modern Pharmaceutical Control FDA Perspective

Multivariate Tools for Modern Pharmaceutical Control FDA Perspective Multivariate Tools for Modern Pharmaceutical Control FDA Perspective IFPAC Annual Meeting 22 January 2013 Christine M. V. Moore, Ph.D. Acting Director ONDQA/CDER/FDA Outline Introduction to Multivariate

More information

In 2001, ISPE issued Baseline Guide Volume

In 2001, ISPE issued Baseline Guide Volume In today s biopharma and pharmaceutical industries, three related, but distinct terms are in common use: commissioning, qualification, and verification. Inconsistent interpretation and application of these

More information

Setting Up A Complaint Handling System. Presented by Sue Jacobs Principal Consultant, QMS Consulting, Inc. Complaint Systems

Setting Up A Complaint Handling System. Presented by Sue Jacobs Principal Consultant, QMS Consulting, Inc. Complaint Systems Setting Up A Complaint Handling System Presented by Sue Jacobs Principal Consultant, QMS Consulting, Inc. January 2008 ~ Orlando, Florida QMS Consulting, Inc. 2008 1 Complaint Systems Written Procedures

More information

QC Micro Webinar Series. Amylin's Improved Aseptic Gowning and Monitoring Program Using MODA Solution

QC Micro Webinar Series. Amylin's Improved Aseptic Gowning and Monitoring Program Using MODA Solution QC Micro Webinar Series Amylin's Improved Aseptic Gowning and Monitoring Program Using MODA Solution Rapid Testing Solutions / Lonza / 07 Jun 2011 Today s Presenters Bob Toal Segment Manager, Informatics

More information

Health Canada s GCP Compliance Program. GCP Information Sessions November 2010

Health Canada s GCP Compliance Program. GCP Information Sessions November 2010 Your Health and Safety... Our priority Votre santé et votre Securité notre priorité Health Canada s GCP Compliance Program GCP Information Sessions November 2010 Objective To describe the role that Health

More information

ISCT Cell Therapy Liaison Meeting AABB Headquarters in Bethesda, MD. Regulatory Considerations for the Use of Software for Manufacturing HCT/P

ISCT Cell Therapy Liaison Meeting AABB Headquarters in Bethesda, MD. Regulatory Considerations for the Use of Software for Manufacturing HCT/P ISCT Cell Therapy Liaison Meeting AABB Headquarters in Bethesda, MD September 10, 2009 David Doleski, Team Leader, Branch 2 Division of Manufacturing and Product Quality (DMPQ) Office of Compliance and

More information

Comparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE

Comparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE Comparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE Dr. Fulvio CARLOTTI, GNOSIS SpA, Corporate QA Director September 26, 2014 Scope of GMP GMP compliance

More information

Medical Device Training Program 2015

Medical Device Training Program 2015 Medical Device Training Introduction Supplementary training and education is often overlooked by medical device professionals until it is triggered by an upcoming FDA or Notified Body and/or ISO 13485

More information

GUIDELINE ON ACTIVE PHARMACEUTICAL INGREDIENT MASTER FILE (APIMF) PROCEDURE 1 (The APIMF procedure guideline does not apply to biological APIs.

GUIDELINE ON ACTIVE PHARMACEUTICAL INGREDIENT MASTER FILE (APIMF) PROCEDURE 1 (The APIMF procedure guideline does not apply to biological APIs. 15 January 2007 GUIDELINE ON ACTIVE PHARMACEUTICAL INGREDIENT MASTER FILE (APIMF) PROCEDURE 1 (The APIMF procedure guideline does not apply to biological APIs.) TABLE OF CONTENTS 1 INTRODUCTION... 2 2

More information

Optimizing Quality Control / Quality Assurance Agents of a Global Sourcing / Procurement Strategy

Optimizing Quality Control / Quality Assurance Agents of a Global Sourcing / Procurement Strategy Optimizing Quality Control / Quality Assurance Agents of a Global Sourcing / Procurement Strategy Global Pharma Sourcing Conference December 6-7, 2011 Philadelphia, USA Nigel J. Smart, Ph.D. Smart Consulting

More information

Computerized System Audits In A GCP Pharmaceutical Laboratory Environment

Computerized System Audits In A GCP Pharmaceutical Laboratory Environment IVTGXP_july06.qxd 6/28/06 1:09 PM Page 36 Computerized System Audits In A GCP Pharmaceutical Laboratory Environment By Maintaining data integrity for both clinical laboratory processes and patient data

More information

LIBRARY GUIDE. Online Courses. March 2012

LIBRARY GUIDE. Online Courses. March 2012 LIBRARY GUIDE Online Courses March 2012 i Table of Contents OVERVIEW..................................................................................... 1 COURSE DESCRIPTIONS (LISTED ALPHABETICALLY)...............................................

More information

Annex 2. WHO guidelines on quality risk management. 1. Introduction 62. 2. Glossary 67 3. Quality risk management process 70

Annex 2. WHO guidelines on quality risk management. 1. Introduction 62. 2. Glossary 67 3. Quality risk management process 70 Annex 2 WHO guidelines on quality risk management 1. Introduction 62 1.1 Background and scope 62 1.2 Principles of quality risk management 64 2. Glossary 67 3. Quality risk management process 70 3.1 Initiating

More information

Table of Contents. Preface 1.0 Introduction 2.0 Scope 3.0 Purpose 4.0 Rationale 5.0 References 6.0 Definitions

Table of Contents. Preface 1.0 Introduction 2.0 Scope 3.0 Purpose 4.0 Rationale 5.0 References 6.0 Definitions Table of Contents Preface 1.0 Introduction 2.0 Scope 3.0 Purpose 4.0 Rationale 5.0 References 6.0 Definitions 7.0 Objectives and User Needs of a Regulatory Audit Report 7.1 Audit report objectives 7.2

More information

ASTRAZENECA GLOBAL POLICY QUALITY AND REGULATORY COMPLIANCE

ASTRAZENECA GLOBAL POLICY QUALITY AND REGULATORY COMPLIANCE ASTRAZENECA GLOBAL POLICY QUALITY AND REGULATORY COMPLIANCE THIS POLICY OUTLINES THE TOP LEVEL REQUIREMENTS TO SUPPORT PRODUCT QUALITY IN THE DEVELOPMENT, MANUFACTURE AND DISTRIBUTION OF ACTIVE PHARMACEUTICAL

More information

Implementation of ANSI/AAMI/IEC 62304 Medical Device Software Lifecycle Processes.

Implementation of ANSI/AAMI/IEC 62304 Medical Device Software Lifecycle Processes. Implementation of ANSI/AAMI/IEC 62304 Medical Device Software Lifecycle Processes.. www.pharmout.net Page 1 of 15 Version-02 1. Scope 1.1. Purpose This paper reviews the implementation of the ANSI/AAMI/IEC

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Process Validation: General Principles and Practices U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center

More information

Working with ICH Quality Guidelines - the Canadian Perspective

Working with ICH Quality Guidelines - the Canadian Perspective Working with ICH Quality Guidelines the Canadian Perspective Krishnan Tirunellai, Ph. D. Bureau of Pharmaceutical Sciences Therapeutic Products Directorate Health Canada December 3, 2008 Outline Introduction

More information

Building an Effective Supplier Control Program: A review of key program elements & their implementation.

Building an Effective Supplier Control Program: A review of key program elements & their implementation. Building an Effective Supplier Control Program: A review of key program elements & their implementation. Jonathan Lee VP RQCS Medtronic Surgical Technologies Building an Effective Supplier Control Program

More information

WHITEPAPER: SOFTWARE APPS AS MEDICAL DEVICES THE REGULATORY LANDSCAPE

WHITEPAPER: SOFTWARE APPS AS MEDICAL DEVICES THE REGULATORY LANDSCAPE WHITEPAPER: SOFTWARE APPS AS MEDICAL DEVICES THE REGULATORY LANDSCAPE White paper produced by Maetrics For more information, please contact global sales +1 610 458 9312 +1 877 623 8742 globalsales@maetrics.com

More information

Product Lifecycle Management in the Medical Device Industry. An Oracle White Paper Updated January 2008

Product Lifecycle Management in the Medical Device Industry. An Oracle White Paper Updated January 2008 Product Lifecycle Management in the Medical Device Industry An Oracle White Paper Updated January 2008 Product Lifecycle Management in the Medical Device Industry PLM technology ensures FDA compliance

More information

Regulations for Handling Samples and Laboratory Testing from R&D through Phase III Clinical Trials

Regulations for Handling Samples and Laboratory Testing from R&D through Phase III Clinical Trials Regulations for Handling Samples and Laboratory Testing from R&D through Phase III Clinical Trials Ron Hinkel, Director Quality Systems BioReliance Inc. Patti Rossman, President Globiox Purpose Keep pace

More information

Supply Chain Challenges and Risk Management

Supply Chain Challenges and Risk Management Supply Chain Challenges and Risk Management Presented by Steve Williams Director SeerPharma P/L 21 st April 2009 PDA April 09 SW 1 Supply Chain - Some Useful Guidance cgmp Annex 8 cgmp Chapter 7 ICH Q7

More information

FDA Title 21 CFR Part 11:Electronic Records; Electronic Signatures; Final Rule (1997)

FDA Title 21 CFR Part 11:Electronic Records; Electronic Signatures; Final Rule (1997) www.qadata.co.za Introduction FDA Title 21 CFR Part 11:Electronic Records; Electronic Signatures; Final Rule (1997) INITIAL REGULATION RELEASED High profile audit findings Industry complaints to wasting

More information

The Ever-increasing Complexity of Biotech Changes - A Pledge for Global Convergence

The Ever-increasing Complexity of Biotech Changes - A Pledge for Global Convergence The Ever-increasing Complexity of Biotech Changes - A Pledge for Global Convergence CMC Strategy Forum, Sorrento, May 7th, 2014 Susanne Ausborn, Pharma Technical Regulatory Policy F. Hoffmann-La Roche,

More information

Waters Quality System Documentation

Waters Quality System Documentation (x) POLICY - Policy ( ) PROCED - Procedure ( ) WKINST Work Instructions 1 of 39 TABLE OF CONTENTS 1. General... 3 1.1 Introduction... 3 1.3 Process Approach... 4 2. Permissible Exclusions And Items Not

More information

NSF Dietary Supplement

NSF Dietary Supplement NSF Dietary Supplement SOP Template Book A guide to achieving and maintaining compliance to 21 CFR 111: Dietary Supplement Good Manufacturing Practices 2 Contents How to Use...4 About NSF Dietary Supplements...5

More information

Pharma Change Control

Pharma Change Control Pharma Change Control Strategies for Successful Company-Wide Implementation From the Editors of The Executive Briefing Series Copyright 2013 by Washington Business Information Inc. All rights reserved.

More information

RECORDS RETENTION AND SECURITY REGULATIONS THINK ABOUT IT!

RECORDS RETENTION AND SECURITY REGULATIONS THINK ABOUT IT! DATA SECURITY MANAGEMENT RECORDS RETENTION AND SECURITY REGULATIONS THINK ABOUT IT! Rebecca Herold, CISSP, CISA, FLMI INSIDE Security; Regulations; Health Insurance Portability and Accountability Act (HIPAA);

More information

Computerised Systems. Seeing the Wood from the Trees

Computerised Systems. Seeing the Wood from the Trees Computerised Systems Seeing the Wood from the Trees Scope WHAT IS A COMPUTERISED SYSTEM? WHY DO WE NEED VALIDATED SYSTEMS? WHAT NEEDS VALIDATING? HOW DO WE PERFORM CSV? WHO DOES WHAT? IT S VALIDATED -

More information

GRADUATE CERTIFICATE IN GOOD MANUFACTURING PRACTICE (GMP) Plan your career for tomorrow and you will be ahead of your competitors

GRADUATE CERTIFICATE IN GOOD MANUFACTURING PRACTICE (GMP) Plan your career for tomorrow and you will be ahead of your competitors GRADUATE CERTIFICATE IN GOOD MANUFACTURING PRACTICE (GMP) Plan your career for tomorrow and you will be ahead of your competitors This course is a distance-learning program that will culminate in a Graduate

More information

The Quality System for Drugs in Germany

The Quality System for Drugs in Germany The Quality System for Drugs in Germany Prof. Dr. Harald G. Schweim Head of Department for Drug Regulatory Affairs Institute for Pharmacy, University of Bonn Former President of the German Federal Institute

More information

Quality Assurance. Disclosure for Lilli Møller Andersen. No relevant financial relationships exist for any issue mentioned in this presentation

Quality Assurance. Disclosure for Lilli Møller Andersen. No relevant financial relationships exist for any issue mentioned in this presentation Quality Assurance Disclosure for Lilli Møller Andersen No relevant financial relationships exist for any issue mentioned in this presentation Agenda Quality Assurance Quality Management System Quality

More information

Management Review to Drive Quality and Business Improvement

Management Review to Drive Quality and Business Improvement Management Review to Drive Quality and Business Improvement Kathy Diemert Senior Director, Strategy and Systems, Global Quality Operations AstraZeneca Pharmaceuticals Alderley Park, UK Ron Stellon Vice

More information

Document and Data Control

Document and Data Control Document and Data Control An Integral Component of Quality Management Companies that produce products with rigorous quality requirements face numerous challenges associated with meeting quality objectives

More information

Risk-Based Change Management Using QbD Principles

Risk-Based Change Management Using QbD Principles Risk-Based Change Management Using QbD Principles Lynne Krummen, Ph.D. VP, Global Head, Technical Regulatory Biologics Genentech, a member of the Roche Group CMC Forum 2013 Tokyo, Japan Presentation Outline

More information

Quality Risk Management - The Medical Device Experience. Niamh Nolan Principal Design Assurance Engineer Boston Scientific

Quality Risk Management - The Medical Device Experience. Niamh Nolan Principal Design Assurance Engineer Boston Scientific Quality Risk Management - The Medical Device Experience Niamh Nolan Principal Design Assurance Engineer Boston Scientific Agenda Intent of Risk Management (RM) and Associated Regulations Overview of RM

More information

Good Clinical Practice 101: An Introduction

Good Clinical Practice 101: An Introduction Good Clinical Practice 101: An Introduction Presented by: Lester Jao Lacorte, MD Medical Officer Commissioner s Fellow Division of Bioresearch Monitoring Office of Compliance Center for Devices and Radiological

More information

Computer System Validation - It s More Than Just Testing

Computer System Validation - It s More Than Just Testing Computer System Validation - It s More Than Just Testing Introduction Computer System Validation is the technical discipline that Life Science companies use to ensure that each Information Technology application

More information

The Concept of Quality in Clinical Research. Dorota Śwituła Senior Clinical Quality Assurance Advisor

The Concept of Quality in Clinical Research. Dorota Śwituła Senior Clinical Quality Assurance Advisor The Concept of Quality in Clinical Research Dorota Śwituła Senior Clinical Quality Assurance Advisor 1 Agenda What is quality? How we define quality in clinical research? The standard components of a Quality

More information

C 5. chemical development contract research custom synthesis cgmp API manufacturing commercial production. Welcome to

C 5. chemical development contract research custom synthesis cgmp API manufacturing commercial production. Welcome to C 5 chemical development contract research custom synthesis cgmp API manufacturing commercial production Welcome to ChemCon Company profile Company profile ChemCon offers outstanding chemical services

More information

U.S. Food and Drug Administration

U.S. Food and Drug Administration U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA s website for reference purposes only. It was current when produced, but is no longer maintained

More information

GAMP5 - a lifecycle management framework for customized bioprocess solutions

GAMP5 - a lifecycle management framework for customized bioprocess solutions GE Healthcare Life Sciences GAMP5 - a lifecycle management framework for customized bioprocess solutions imagination at work GE Healthcare s engineering department, Customized Bioprocess Solutions (CBS),

More information

QUALITY MANUAL ISO 9001. Quality Management System

QUALITY MANUAL ISO 9001. Quality Management System Page 1 of 20 QUALITY MANUAL ISO 9001 Quality Management System Printed copies are not controlled unless marked "CONTROLLED". Upon receipt of this document, discard all previous copies. Page 2 of 20 Approval

More information

Data Governance Planning PDA 12 May 2015

Data Governance Planning PDA 12 May 2015 Data Governance Planning PDA 12 May 2015 1 Agenda Overview of Data Integrity Assurance of Data Data Governance The Data Governance Plan Questions 2 Overview of Data Integrity 3 Data Information derived

More information

DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only. Document issued on: July 2015

DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only. Document issued on: July 2015 Third-Party Auditor/Certification Body Accreditation for Food Safety Audits: Model Accreditation Standards Draft Guidance for Industry and Food and Drug Administration Staff DRAFT GUIDANCE This guidance

More information

Quality by Design Approaches to Analytical Methods -- FDA Perspective. Yubing Tang, Ph.D. FDA/CDER/ONDQA AAPS, Washington DC October 25, 2011

Quality by Design Approaches to Analytical Methods -- FDA Perspective. Yubing Tang, Ph.D. FDA/CDER/ONDQA AAPS, Washington DC October 25, 2011 Quality by Design Approaches to Analytical Methods -- FDA Perspective Yubing Tang, Ph.D. FDA/CDER/ONDQA AAPS, Washington DC October 25, 2011 1 Outline What is Quality by Design (QbD) Role of Analytical

More information

Pharmaceutical Quality Systems (ICH Q10) Conference. Business Case for Quality

Pharmaceutical Quality Systems (ICH Q10) Conference. Business Case for Quality Pharmaceutical Quality Systems (ICH Q10) Conference Business Case for Quality Jeffrey Macher, PhD Associate Professor McDonough School of Business Georgetown University Presentation Agenda Business Case

More information

Uncontrolled Document

Uncontrolled Document SOUTHWEST RESEARCH INSTITUTE QUALITY SYSTEM MANUAL July 2015 Revision 5 Quality System Manual Page iii TABLE OF CONTENTS 1.0 PURPOSE... 1 2.0 SCOPE... 1 3.0 TERMS AND DEFINITIONS... 2 4.0 QUALITY MANAGEMENT

More information

Clinical Trial Oversight: Ensuring GCP Compliance, Patient Safety and Data Integrity

Clinical Trial Oversight: Ensuring GCP Compliance, Patient Safety and Data Integrity Clinical Trial Oversight: Ensuring GCP Compliance, Patient Safety and Data Integrity Michelle Quaye Regulatory Manager, Advanced Therapy Trials University College London Overview The Principles of Good

More information

Medical Device Software - Software Life Cycle Processes

Medical Device Software - Software Life Cycle Processes 1 Medical Device Software - Software Life Cycle Processes IEC 62304 2 Credits John F. Murray Software Compliance Expert U.S. Food and Drug Administration Marcie R. Williams Medical Device Fellow Ph.D.

More information

M-Files QMS. Out-of-the-Box Solution for Daily Quality Management

M-Files QMS. Out-of-the-Box Solution for Daily Quality Management M-Files QMS Out-of-the-Box Solution for Daily Quality Management Topics How we see Quality Management Benefits of a dedicated QMS M-Files QMS system essentials Built-in electronic and digital signing QMS

More information

FINE LOGISTICS. Quality Manual. Document No.: 20008. Revision: A

FINE LOGISTICS. Quality Manual. Document No.: 20008. Revision: A FINE LOGISTICS Quality Manual Document No.: 20008 Revision: A 20008 Rev. A FINE LOGISTICS, Quality Manual Page 1 of 24 Quality Manual: Table of contents Number Section Page 1. GENERAL 3 1.1 Index and revision

More information

Quality Management Systems Manual

Quality Management Systems Manual Washington Division Quality Management Systems Manual ISO 13485:2003 DOCUMENT NUMBER 01-QM-MED REVISION LEVEL 01 PAGE 1 of 40 This manual describes the quality management systems structure at GM Nameplate

More information

Quality Metrics An FDA Perspective PDA Dinner and Dialogue. Melissa Seymour VP, Corporate Quality DRAFT

Quality Metrics An FDA Perspective PDA Dinner and Dialogue. Melissa Seymour VP, Corporate Quality DRAFT Quality Metrics An FDA Perspective PDA Dinner and Dialogue Melissa Seymour VP, Corporate Quality DRAFT Agenda How does industry use Metrics? FDA Challenges and Requirements and Use Complexities of Implementation

More information

21 CFR Part 11 Checklist

21 CFR Part 11 Checklist 21 CFR Part 11 Checklist GUIDE NOTOCORD - 113 Chemin de Ronde - 78290 Croissy-sur-Seine www.notocord.com my.notocord.com support@notocord.com +33 (0)1 34 80 00 00 1. Preliminary information 1.1. Purpose

More information

QUALITY CONTROL AND QUALITY ASSURANCE IN CLINICAL RESEARCH

QUALITY CONTROL AND QUALITY ASSURANCE IN CLINICAL RESEARCH QUALITY CONTROL AND QUALITY ASSURANCE IN CLINICAL RESEARCH Martin Valania, Executive Director, Corporate QA and Compliance Introduction Pharmaceutical companies recognize the benefits of carefully managing

More information

Quality Management System MANUAL. SDIX, LLC Headquarters: 111 Pencader Drive Newark, Delaware 19702

Quality Management System MANUAL. SDIX, LLC Headquarters: 111 Pencader Drive Newark, Delaware 19702 Quality Management System MANUAL SDIX, LLC Headquarters: 111 Pencader Drive Newark, Delaware 19702 Doc. No. G5500 Rev. 9.1 Status : APPROVED Effective: 12/11/2014 Page 2 of 23 Quality Manual Table of Contents

More information

Quality Management System MANUAL. SDIX, LLC Headquarters: 111 Pencader Drive Newark, Delaware 19702

Quality Management System MANUAL. SDIX, LLC Headquarters: 111 Pencader Drive Newark, Delaware 19702 Quality Management System MANUAL SDIX, LLC Headquarters: 111 Pencader Drive Newark, Delaware 19702 Doc. No. G5500 Rev. 9.2 Status : APPROVED Effective: 9/25/2015 Page 2 of 23 Quality Manual Table of Contents

More information

Application of Quality Risk Management to Pharmaceutical Operations. Eldon Henson, Vice President, Quality Operations

Application of Quality Risk Management to Pharmaceutical Operations. Eldon Henson, Vice President, Quality Operations Application of Quality Risk Management to Pharmaceutical Operations Eldon Henson, Vice President, Quality Operations Key Topics of Discussion Definition of Quality Risk Management (QRM) Overview of PDA

More information

Pharmaceutical Product Quality, Quality by Design, cgmp, and Quality Metrics

Pharmaceutical Product Quality, Quality by Design, cgmp, and Quality Metrics Pharmaceutical Product Quality, Quality by Design, cgmp, and Quality Metrics Lawrence X. Yu, Ph.D. Deputy Director Office of Pharmaceutical Quality Center for Drug Evaluation and Research Food and Drug

More information

Health Canada s GCP Compliance Program Part 2. GCP Information Sessions November 2010

Health Canada s GCP Compliance Program Part 2. GCP Information Sessions November 2010 Your Health and Safety... Our priority Votre santé et votre Securité notre priorité Health Canada s GCP Compliance Program Part 2 GCP Information Sessions November 2010 Inspection Program Main objectives

More information

Gap Analysis of the Change Control Process The History of a Transformed Change Control System

Gap Analysis of the Change Control Process The History of a Transformed Change Control System Gap Analysis of the Change Control Process The History of a Transformed Change Control System Juan Alcazar Quality Systems Carolina, PR Content Introduction Gap Analysis Phases to perform a Gap Analysis

More information

Quality Manual # QS001.3. MD Logistics, Inc. (Signed copy available upon request) Prepared by Robert Grange, Director Quality

Quality Manual # QS001.3. MD Logistics, Inc. (Signed copy available upon request) Prepared by Robert Grange, Director Quality # QS001.3 MD Logistics, Inc. (Signed copy available upon request) Prepared by Robert Grange, Director Quality Date Review indicates that qualified persons from operational areas have reviewed the content

More information

Diane Kadidlo MT(ASCP) SBB University of Minnesota Joanna Stanson, M.S. University of Pittsburgh

Diane Kadidlo MT(ASCP) SBB University of Minnesota Joanna Stanson, M.S. University of Pittsburgh Production Records & Documentation Diane Kadidlo MT(ASCP) SBB University of Minnesota Joanna Stanson, M.S. University of Pittsburgh Production Records This Session: Production Records Basic Elements Regulatory

More information

MHRA Data Integrity Guidance and Expectations Document

MHRA Data Integrity Guidance and Expectations Document MHRA Data Integrity Guidance and Expectations Document Nichola Stevens Alere International John Andrews Integrity Solutions April 23 rd 2015, Astellas, Chertsey 1 About this Session This is an interactive

More information

Vigilant Security Services UK Ltd Quality Manual

Vigilant Security Services UK Ltd Quality Manual Quality Manual Date: 11 th March, 2014 Issue: 5 Review Date: 10 th March 2015 VSS-COM-PRO-001 SCOPE This Quality Manual specifies the requirements for the Quality Management System of Vigilant Security

More information

Designing a CDS Landscape that Ensures You Address the Latest Challenges of the Regulatory Bodies with Ease and Confidence

Designing a CDS Landscape that Ensures You Address the Latest Challenges of the Regulatory Bodies with Ease and Confidence Designing a CDS Landscape that Ensures You Address the Latest Challenges of the Regulatory Bodies with Ease and Confidence Heather Longden Senior Marketing Manager, Informatics Regulatory Compliance 2015

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Q9 Quality Risk Management U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation

More information

Assessment Plan. concepts of quality assurance: (1) Quality, safety, and effectiveness must be designed and built

Assessment Plan. concepts of quality assurance: (1) Quality, safety, and effectiveness must be designed and built Software Supplier Assessment Plan The life cycle for software parallels that for a computer system. It begins during the analysis of the requirements... by Robert W. Stotz, Ph.D. Manager of Validation

More information

Security Controls What Works. Southside Virginia Community College: Security Awareness

Security Controls What Works. Southside Virginia Community College: Security Awareness Security Controls What Works Southside Virginia Community College: Security Awareness Session Overview Identification of Information Security Drivers Identification of Regulations and Acts Introduction

More information

Using Training Data to Drive Up Quality Metrics SURVEY OF QUALITY ASSURANCE EXECUTIVES

Using Training Data to Drive Up Quality Metrics SURVEY OF QUALITY ASSURANCE EXECUTIVES Using Training Data to Drive Up Quality Metrics SURVEY OF QUALITY ASSURANCE EXECUTIVES SURVEY OF QUALITY ASSURANCE EXECUTIVES The FDA s Push for Data and Metrics For the US FDA investigator, the single

More information

Conformity assessment certification

Conformity assessment certification TGA use only This form, when completed, will be classified as 'For official use only'. For guidance on how your information will be treated by the TGA see: Treatment of information provided to the TGA

More information